相关实验视频

Updated: Jul 7, 2025

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

一个多重复的免疫化学微阵列用于确定心血管疾病生物标志物

Gloria Colom^1,2, Alejandro Hernandez-Albors^1,2, Jaume Barallat³

¹Nanobiotechnology for Diagnostics (Nb4D), Department of Chemical and Biomolecular Nanotechnology, Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish Council for Scientific Research (CSIC), Jordi Girona 18-26, 08034, Barcelona, Spain.

Mikrochimica acta

|December 27, 2023

概括

一种新的光抗体微阵列使得在血中同时检测到五种心血管疾病生物标志物. 这种快速,信息丰富的诊断工具有助于早期发现和监测疾病,为心血管健康评估提供了强大的方法.

科学领域:

生物技术是生物技术.
心血管医学心血管医学
诊断诊断诊断诊断

背景情况:

心血管疾病 (CVDs) 是复杂的,需要先进的诊断工具来准确的阶段和预后.
目前的诊断方法可能缺乏有效的心血管疾病管理所需的速度和全面信息.
多重生物标志物分析有望对心血管健康进行更全面的评估.

研究的目的:

开发和验证一种新的光抗体微阵列,用于同时确定人体血中的关键心血管疾病生物标志物.
评估这种微阵列技术在快速心血管疾病诊断,分期和监测方面的潜力.
与现有的医院实验室技术相比,评估微阵列的临床实用性.

主要方法:

多重光抗体微阵列的开发和优化.
同时检测五个关键生物标志物:C-反应蛋白 (CRP),囊素C (CysC),心脏热素I (cTnI),心脏脂肪酸结合蛋白 (H-FABP) 和NT-proBNP.
使用缓冲溶液进行测试验证,并对29名患者的血样本进行试点临床研究.

主要成果:

优化的微阵列实现了所有五种生物标志物的低检测极限.
在处理矩阵效应后,测试显示了准确性,使得每个芯片可以分析24个样本.
一项试点研究表明,与参考技术相比,芯片具有快速,信息丰富的分析能力 (1.5小时的周转时间).

结论:

开发的光抗体微阵列是用于同时快速检测多个心血管疾病生物标志物的强大工具.
这项技术显示出早期心血管疾病诊断,疾病进展监测和风险评估的巨大潜力.
微阵列平台为心血管医学及其他领域的多重诊断提供了有前途的进展.

关键词:

剧烈的心肌梗塞急性心肌梗塞光检测的检测方法心脏衰竭是因为心脏衰竭.免疫测试是一种免疫测试.炎症的光是因为炎症的光.微阵列的微阵列多重复合是一种多重复合.

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...